New technique identifies pathogens in patient samples faster, in great detail

The investigators used a technique known as whole genome sequencing to identify and completely characterize bacteria causing urinary tract infections. In just 18 hours, they identified the culprit microorganisms, characterized the pathogens' patterns of antibiotic susceptibility, and identified specific strains.

“Using conventional methodologies this would have taken several days to weeks, and even using whole genome sequencing on cultured bacteria would have taken an extra day,” says Frank M. Aarestrup of the Technical University of Denmark, Lyngby, an author on the study.

Their work will help patients heal more quickly and avoid unnecessarily prolonged illness and even death. It will also help prevent outbreaks of hospital-acquired disease, and identify emerging infections.

“Rapid identification of the causative agent, and of any antibiotic resistance is crucial to choosing the correct treatment for individual patients,” says Aarestrup. “Choosing the wrong antibiotic will lead to longer infections and in the worst case, deaths.”

The investigators also identified bacteria in the patient samples that they did not detect using conventional techniques. “Lactobacillus iners, Gardnerella vaginalis, Prevotella, and A. urinae have all been implicated in [urinary tract infections], even though their precise roles as pathogens and normal colonizers of the genital tract have not been firmly established,” write the researchers. They note that by conventional methods A. urinae is rarely identified but frequently misclassified.

The ability to identify strains in patients with repeated infections enables the doctor to know whether the patient's infection is new, or recurrent. And the typing of bacterial strains enables rapid comparison of bacteria from different patients, so that doctors can detect the spread of infections within the hospital, and identify emerging infections.

“Whole genome sequencing may still be too expensive for routine use in most clinical microbial laboratories,” the researchers write. But they predict that rapidly falling prices and automation will render it a standard technology for infection detection and control, in and out of the hospital.

A copy of the manuscript can be found online at http://bit.ly/asmtip1113c.

The Journal of Clinical Microbiology is a publication of the American Society for Microbiology (ASM). The ASM is the largest single life science society, composed of over 39,000 scientists and health professionals. Its mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.

Media Contact

Jim Sliwa EurekAlert!

More Information:

http://www.asmusa.org

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Recovering phosphorus from sewage sludge ash

Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Partners & Sponsors